drugset / Trial / NCT01690286

Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers

NCT01690286

Phase 1 Completed 33 enrolled Janssen Research & Development, LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of repeated twice-daily administration of 200 mg ketoconazole on the steady-state pharmacokinetics of JNJ-38518168.

Timeline

Start
2012-10
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 200 mg Oral
Subject TOREFORANT Small molecule 3 mg Oral
Subject TOREFORANT Small molecule 10 mg Oral
Subject TOREFORANT Small molecule 30 mg Oral

Indications

No indication recorded.